REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 209 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $551,118 | -26.7% | 5,406 | -34.6% | 0.00% | 0.0% |
Q1 2023 | $751,637 | +1197.0% | 8,269 | +432.8% | 0.00% | – |
Q4 2022 | $57,950 | – | 1,552 | +5442.9% | 0.00% | – |
Q3 2022 | $0 | – | 28 | -28.2% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 39 | -84.0% | 0.00% | – |
Q1 2022 | $7,000 | +16.7% | 243 | +8.0% | 0.00% | – |
Q4 2021 | $6,000 | -95.7% | 225 | -83.2% | 0.00% | – |
Q3 2021 | $138,000 | -42.5% | 1,340 | -20.5% | 0.00% | -100.0% |
Q2 2021 | $240,000 | +7.6% | 1,686 | -24.7% | 0.00% | 0.0% |
Q1 2021 | $223,000 | -27.1% | 2,239 | -9.6% | 0.00% | 0.0% |
Q4 2020 | $306,000 | +66.3% | 2,476 | +31.1% | 0.00% | 0.0% |
Q3 2020 | $184,000 | +607.7% | 1,888 | +1058.3% | 0.00% | – |
Q2 2020 | $26,000 | – | 163 | +3160.0% | 0.00% | – |
Q1 2020 | $0 | – | 5 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |